Signal active
Organization
Contact Information
Overview
Biom is a manufacturer of environmentally friendly wipes with the goal of reducing plastic waste and establishing recycling systems. The firm wipes are manufactured with no plastics and just natural chemicals, allowing customers to stay safe and sanitary at an affordable price.
About
Health Care, Consumer Goods, Wellness, Home Decor, Personal Health
2020
1-10
Headquarters locations
Charleston, South Carolina, United States, North America
Social
Profile Resume
Biom headquartered in United States, North America, operates in the Health Care, Consumer Goods, Wellness, Home Decor, Personal Health sector. The company focuses on Health Care and has secured $64.0M in funding across 40 round(s). With a team of 1-10 employees, Biom is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Biom, raised $1.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
2
5
0
$1.6M
Details
2
Biom has raised a total of $1.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 600.0K | ||
2022 | Seed | 1.0M |
Investors
Biom is funded by 4 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Pure Ventures | - | FUNDING ROUND - Pure Ventures | 1.0M |
SuperAngel.Fund | - | FUNDING ROUND - SuperAngel.Fund | 1.0M |
Biom | - | FUNDING ROUND - Biom | 1.0M |
Brandon Child | - | FUNDING ROUND - Brandon Child | 1.0M |
Recent Activity
News
Sep 20, 2024
Food Business News - bioMérieux holds grand opening of Molecular and Genomic Innovation Center
News
Sep 04, 2024
thefly.com - BioMarin revenue guidance above consensus, says Cantor Fitzgerald
News
Aug 23, 2024
FierceBiotech - Chutes & Ladders—BioMarin builds executive team with biotech vets
News
May 28, 2024
MarketScreener - BioMérieux: FDA clearance for Vidas TBI test
News
May 23, 2024
MarketScreener - bioMérieux : Back on an important level
News
Apr 26, 2024
MarketScreener - BioMérieux: share price rises, analyst remains Buy